Sign In
Buy SGEN
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Get ready for more merger mania in pharma sector the rest of the year
02:43pm, Tuesday, 09'th Aug 2022
Pfizer Inc.'s PFE, +0.24% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, +0.02% is the latest sign that cash-flush drug makers are ready to jump back into dealmaking.
These eight health-care stocks can keep you invested in the market with less worry
10:52am, Tuesday, 02'nd Aug 2022
You're tempted to increase exposure to stocks because of the market's strength. But you're still gun shy because of the painful selloff.
Seagen's (SGEN) Earnings & Revenues Surpass Estimates in Q2
05:07pm, Friday, 29'th Jul 2022
Seagen (SGEN) reports a narrower-than-expected loss in the second quarter of 2022 while its revenues beat estimates.
Seagen Inc. (SGEN) CEO Roger Dansey on Q2 2022 Results - Earnings Call Transcript
11:45pm, Thursday, 28'th Jul 2022
Seagen Inc. (NASDAQ:SGEN ) Q2 2022 Earnings Conference Call July 28, 2022 4:30 PM ET Company Participants Douglas Maffei - Vice President of Investor Relations Roger Dansey - Chief Medical Officer & I
Seattle Genetics (SGEN) Reports Q2 Loss, Tops Revenue Estimates
06:44pm, Thursday, 28'th Jul 2022
Seattle Genetics (SGEN) delivered earnings and revenue surprises of 10.98% and 12.26%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Seagen Tips Its Hand In Bladder Cancer, But Is It Enough To Woo Merck?
10:17am, Tuesday, 26'th Jul 2022
Nearly two-thirds of bladder cancer patients responded to a combination from Seagen and Merck, leading SGEN stock to jump Tuesday. The post Seagen Tips Its Hand In Bladder Cancer, But Is It Enough To
Seagen shares positive data for bladder cancer drug; stock is up 2.5%
07:30am, Tuesday, 26'th Jul 2022
Shares of Seagen Inc. SGEN, +0.71% gained 2.5% in premarket trading on Tuesday after the company said an early-stage clinical trial evaluating its investigational treatment for urothelial cancer in co
Merck deal for Seagen unlikely to be finalized ahead of earnings later this month, sources say
06:33pm, Friday, 15'th Jul 2022
Merck & Co.'s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized ahead of the pharmaceutical giant's earnings later this month, though the talks remain on track, according to people
Seattle Genetics (SGEN) Now Trades Above Golden Cross: Time to Buy?
11:32am, Wednesday, 13'th Jul 2022
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
Seagen to Host Conference Call and Webcast Discussion of Second Quarter 2022 Financial Results on July 28, 2022
08:00am, Friday, 08'th Jul 2022
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq: SGEN) today announced that it will report its second quarter 2022 financial results on Thursday, July 28, 2022 after the close of U.S. financial m
The direction of M&A in biotech is very, very vast, says Oppenheimer's Holz
03:24pm, Thursday, 07'th Jul 2022
Jared Holz, Oppenheimer healthcare equity strategist, joins 'Power Lunch' to discuss the possibility of M&A in the healthcare sector, if investors remain focused on the oncology side of healthcare bus
Merck nears Seagen takeover: ‘question is how does FTC look at this?'
01:05pm, Thursday, 07'th Jul 2022
Shares of Seagen Inc (NASDAQ: SGEN) are up 3.0% this morning on a report that Merck & Co Inc (NYSE: MRK) is in advanced talks to buy the cancer drug specialist for at least $40 billion. Dr Gottlieb re
Seagen (SGEN) Stock Pops on Merck Buyout Rumors
11:58am, Thursday, 07'th Jul 2022
Seagen (SGEN) stock is getting a boost on Thursday as rumors circulate that Merck (MRK) is considering a buyout of the biotechnology company. The post Seagen (SGEN) Stock Pops on Merck Buyout Rumors a
Merck nears $40 billion deal for Seagen, report says
11:08am, Thursday, 07'th Jul 2022
Pharma giant Merck is in advanced talks to acquire biotech Seagen in a deal valued at roughly $40 billion, according to a Wall Street Journal report.
Merck in advanced talks to buy biotech company Seagen
10:30am, Thursday, 07'th Jul 2022
Yahoo Finance Live anchors discuss reports of an acquisition deal between Merck and Seagen.
